Found: 4
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 45–52
Kachalov K.S., Solomina A.S., Rodina A.V., Kulakova A.V., Zhanataev A.K., Durnev A.D.
Introduction. Hyperglycemia inducers, the «classic» diabetogens streptozotocin and alloxan have a pronounced effect and are therefore limited suitable for modeling mild hyperglycemia in an experiment. Tyloxapol (Triton WR1339) was chosen as an alternative agen…
ОБЗОР2021
Chaulin A.M., Duplyakov D.V.
Due to the discovery of the proprotein convertase subtilisin/kexin type 9 (PCSK9) and the establishment of its role in lipoprotein metabolism, it became possible to deliver new groups of effective drugs for the treatment of dyslipidemia. The main function of P…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017
Kotlovskiy M.Yu., Pokrovskiy A.A., Osedko A.V., Osedko O.Ya., Kotlovskaya O.S., Yakimenko A.V., Kurdoyak E.V., Yakimovich I.Yu., Aksyutina N.V., Titova N.M., Kotlovskiy Yu.V., Dygai A.M.
Introduction. Carrier protein OATP1B1, encoded by the SLCO1B1gene, is involved in the transport of simvastatin into liver cells. SLCO1B1 gene polymorphisms influence on the functionality of the transporter, which could reflect on the efficacy and safety of tre…
Research article2013
Yurieva E.A., Sukhorukov V.S., Tsaregorodtsev A.D., Vozdvizhenskaya E.S., Kharabadze M.N., Novikova N.N., Kovalchuk M.V.
The enhancement of ligand properties of protein molecules treated by toxic reagents has been revealed in model experiments in vitro on ordered protein films. In patients with endogenous intoxication caused by metabolic disorders there were also detected protei…